Literature DB >> 27138790

Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β.

Shakir M Saud1, Weidong Li2, Zane Gray3, Matthias S Matter4, Nancy H Colburn5, Matthew R Young6, Young S Kim7.   

Abstract

There is a strong belief that garlic has medicinal properties and may even reduce the risk of developing certain cancers including those of the gastrointestinal tract. The chemopreventive effects of garlic may be attributed to the anti-inflammatory properties of the sulfur-containing constituents of garlic, which includes diallyl disulfide (DADS). Here, we demonstrate that DADS prevented colorectal tumorigenesis in a mouse model of colitis-induced colorectal cancer. Supplementation with 85 ppm of DADS (60 mg daily human equivalent dose) in the diet of FVB/N mice treated with chemical carcinogen azoxymethane (AOM) and colonic irritant dextran sodium sulfate (DSS) resulted in the reduction in tumor incidence, tumor number, and tumor burden by 21.54%, 47.3%, and 66.4%, respectively. Further analysis revealed that mice fed the DADS-supplemented diet resolved the initial DSS-induced inflammation faster than those on the control diet, preventing prolonged inflammation and cellular transformation. Subsequent mechanistic studies in vitro suggest that DADS chemopreventive effects are mediated through NF-κB signaling. When SW480 colorectal cancer cells were treated with DADS, NF-κB nuclear localization and activity were diminished. Interestingly, NF-κB suppression was found to be dependent on DADS inhibition of GSK-3β, a positive regulator of NF-κB. Inhibition of GSK-3β and loss of nuclear NF-κB activity were also observed in vivo in AOM/DSS-treated mice fed a diet supplemented with 85 ppm DADS. Our results indicate that DADS can prevent tumorigenesis by suppressing inflammation, a process largely involving GSK-3β inhibition and consequential reduction in NF-κB nuclear localization. Cancer Prev Res; 9(7); 607-15. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27138790      PMCID: PMC4930730          DOI: 10.1158/1940-6207.CAPR-16-0044

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  50 in total

1.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 2.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

3.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

Authors:  Tine Jess; Christine Rungoe; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 4.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

5.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Authors:  K P Hoeflich; J Luo; E A Rubie; M S Tsao; O Jin; J R Woodgett
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

6.  Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.

Authors:  R J Coffey; A S Goustin; A M Soderquist; G D Shipley; J Wolfshohl; G Carpenter; H L Moses
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

Review 7.  NF-kappaB in inflammatory bowel disease.

Authors:  I Atreya; R Atreya; M F Neurath
Journal:  J Intern Med       Date:  2008-06       Impact factor: 8.989

8.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

9.  Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography.

Authors:  Matthew R Young; Lilia V Ileva; Marcelino Bernardo; Lisa A Riffle; Yava L Jones; Young S Kim; Nancy H Colburn; Peter L Choyke
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

Review 10.  NF-κB in cellular senescence and cancer treatment.

Authors:  Hua Jing; Soyoung Lee
Journal:  Mol Cells       Date:  2014-03-03       Impact factor: 5.034

View more
  18 in total

Review 1.  Allicin in Digestive System Cancer: From Biological Effects to Clinical Treatment.

Authors:  Yang Zhou; Xingxuan Li; Wenyu Luo; Junfeng Zhu; Jingwen Zhao; Mengyao Wang; Lixuan Sang; Bing Chang; Bingyuan Wang
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

Review 2.  Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review.

Authors:  Md Sanower Hossain; Md Abdul Kader; Khang Wen Goh; Maidul Islam; Md Sharif Khan; Md Harun-Ar Rashid; Der Jiun Ooi; Henrique Douglas Melo Coutinho; Yaser Mohammed Al-Worafi; Said Moshawih; Ya Chee Lim; K M Kaderi Kibria; Long Chiau Ming
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

3.  Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment.

Authors:  Qingye Li; Yuxian Tang; Jing Qin; Lan Yi; Yening Yang; Juan Wang; Jie He; Qi Su; Hui Tan
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

Review 4.  Therapeutic Role of Functional Components in Alliums for Preventive Chronic Disease in Human Being.

Authors:  Yawen Zeng; Yuping Li; Jiazhen Yang; Xiaoying Pu; Juan Du; Xiaomeng Yang; Tao Yang; Shuming Yang
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-05       Impact factor: 2.629

5.  Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.

Authors:  Jian Su; Yujuan Zhou; Zhibing Pan; Ling Shi; Jing Yang; Aijun Liao; Qianjin Liao; Qi Su
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

6.  Dietary and the Risk of Sporadic Colorectal Cancer in China: A Case-control Study.

Authors:  Wenfei Wang; Zhaogang Dong; Xin Zhang; Wei Li; Peilong Li; Xiaoyang Chen
Journal:  Iran J Public Health       Date:  2018-09       Impact factor: 1.429

7.  Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB-NFATc1 signal pathway.

Authors:  Jing Yang; Ruohui Tang; Jin Yi; Yueqi Chen; Xianghe Li; Tao Yu; Jun Fei
Journal:  FASEB J       Date:  2019-03-11       Impact factor: 5.191

Review 8.  Phytochemicals and Gastrointestinal Cancer: Cellular Mechanisms and Effects to Change Cancer Progression.

Authors:  Raghad Khalid Al-Ishaq; Anthony J Overy; Dietrich Büsselberg
Journal:  Biomolecules       Date:  2020-01-08

Review 9.  Immunomodulatory Effects of Glutathione, Garlic Derivatives, and Hydrogen Sulfide.

Authors:  Camila Rodrigues; Susan S Percival
Journal:  Nutrients       Date:  2019-01-30       Impact factor: 5.717

10.  Diallyl Disulfide Suppresses Inflammatory and Oxidative Machineries following Carrageenan Injection-Induced Paw Edema in Mice.

Authors:  Hongxing Zhang; Chi Shang; Zhao Tian; Hatem K Amin; Rami B Kassab; Ahmed E Abdel Moneim; Yingang Zhang
Journal:  Mediators Inflamm       Date:  2020-04-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.